NewLimit
$3.10B
Epigenetic reprogramming medicines for age-related diseases
- $3.10B last priced transaction (as of 2026-06)
- 7 sourced signals across 2 data sources
Loading the full interactive profile on VizierAtlas…
Epigenetic reprogramming medicines for age-related diseases
Loading the full interactive profile on VizierAtlas…